Use of GLP-1 receptor agonist and risk of osteoporosis among patients with type 2 diabetes: a real-world study
In a major step forward, the FDA approved the first generic liraglutide for weight loss in August 2025, making these treatments more affordable
Factors that influence early weight loss include starting body weight, baseline diet quality, physical activity level, hydration status, and individual metabolic rate
Yet it is Lillys newest drug, tirzepatide, which poses a more serious threat to Novos market dominance
always inspect solution for clarity (discard if cloudy or contains particles) [10]
Hydration: Drinking at least 64 ounces of water daily supports metabolic function and helps manage side effects